Our data demonstrate that NID2 overexpression in male mice promotes hepatic steatosis, as evidenced by increased triglyceride, NEFA levels, and ORO staining of liver frozen sections, as well as increased plasma triglycerides. This evidence concerns the gene NID2 and fatty liver disease.